Novel monoclonal antibody-based therapies: Implications for the treatment and prevention of HCMV disease
M Nuévalos, E García-Ríos, FJ Mancebo… - Trends in …, 2023 - cell.com
Human cytomegalovirus (HCMV) is an important pathogen worldwide. Although HCMV
infection is often asymptomatic in immunocompetent individuals, it can cause severe or even …
infection is often asymptomatic in immunocompetent individuals, it can cause severe or even …
[HTML][HTML] ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
Human cytomegalovirus (HCMV) is the most common vertically transmitted infection
worldwide, yet there are no vaccines or therapeutics to prevent congenital HCMV (cCMV) …
worldwide, yet there are no vaccines or therapeutics to prevent congenital HCMV (cCMV) …
Human Cytomegalovirus mRNA-1647 vaccine candidate elicits potent and broad neutralization and higher antibody-dependent cellular cytotoxicity responses than …
X Hu, KP Karthigeyan, S Herbek… - The Journal of …, 2024 - academic.oup.com
Background MF59-adjuvanted gB subunit (gB/MF59) vaccine demonstrated approximately
50% efficacy against human cytomegalovirus (HCMV) acquisition in multiple clinical trials …
50% efficacy against human cytomegalovirus (HCMV) acquisition in multiple clinical trials …
[HTML][HTML] Evaluating longitudinal cytomegalovirus-specific humoral immune responses and association with DNAemia risk in seropositive lung transplant recipients
MJ Harnois, R Barfield, M Dennis, N Rodgers, J Pollara… - JHLT Open, 2024 - Elsevier
Background Cytomegalovirus (CMV) is the most common viral infection among lung
transplant recipients and is associated with chronic lung allograft dysfunction. There is a …
transplant recipients and is associated with chronic lung allograft dysfunction. There is a …